The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Clinical research

First-in-human evaluation of the novel BioMime sirolimus-eluting coronary stent with bioabsorbable polymer for the treatment of single de novo lesions located in native coronary vessels - results from the meriT-1 trial

EuroIntervention 2013;9:493-500. DOI: 10.4244/EIJV9I4A79

1. Lifecare Institute of Medical Sciences and Research, Ahmedabad, Gujarat, India; 2. Instituto Dante Pazzanese de Cardiologia, São Paulo, SP, Brazil; 3. Cardiovascular Research Center, São Paulo, SP, Brazil; 4. CV Path Institute, Inc.,

Aims: We report the initial human evaluation of the novel BioMimeTM sirolimus-eluting stent (SES) (Meril Life Scie

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article

Everolimus-eluting bioresorbable vascular scaffold (BVS) implantation in patients with ST-segment elevation myocardial infarction (STEMI)